Last updated: 2026-10-14 11:36:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
ClearPoint Neuro, Inc. (CLPT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9.97, with a market capitalisation of $311.14M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.27 to $28.10. This page covers its latest market performance, valuation, price trends and company information.
$311.14M | |
$10.20 | |
$31.29 | |
$2.86 | |
$9.81 | |
8.14K | |
649.73K | |
-- | |
$28.10 | |
$8.27 | |
-- | |
-- |
ClearPoint Neuro, Inc. (CLPT) is trading at $9.97 in pre-market trading as of 2026-10-14 11:09:00, up 1.64% ($0.16) from the previous close of $9.81
Pre-market trading shows how investors are pricing CLPT before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, ClearPoint Neuro, Inc. (CLPT) moved from $11.52 to $9.97, representing a decline of 13.45% ($1.55).
The stock traded between $9.72 and $11.74 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 639.00 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 8.6%
CLPT is currently trading at $9.97, placing it 8.6% of the way from its 52-week low of $8.27 to its 52-week high of $28.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 172 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ClearPoint Neuro, Inc. (CLPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.